CA17140 Publications

The following is a list of all scientific publications resulting exclusively from joint efforts among CA17140 members. OA marks contributions published under Open Access policy; accordingly, the OA PDFs are made available for download from the relevant paper's page on this website.

 













  • Catalano E. Nanomedicine strategies for chemoresistance breast cancer theranostics. In Nanomedicines for Breast Cancer Theranostics, Nanasaheb D. Thorat and Joanna Bauer Editors, Elsevier Inc. Chapter 9, pp. 175-189 (2020). Copyright (C) 2020 Elsevier B.V.


  • Aulic S, Marson D, Laurini E, Fermeglia M, Pricl S. Breast cancer nanomedicine market update and other industrial perspectives of nanomedicine. In Nanomedicines for Breast Cancer Theranostics, Nanasaheb D. Thorat and Joanna Bauer Editors, Elsevier Inc. Chapter 16, pp. 395-404 (2020). Copyright (C) 2020 Elsevier B.V.





































 

IMPORTANT NOTICE: CA17140 publications must report the following official sentence in the acknowledgment section:

This article/publication is based upon work from COST Action CA 17140 "Cancer Nanomedicine from the Bench to the Bedside" supported by COST (European Cooperation in Science and Technology).

 

All applicants must carefully read the funding rules detailed on the COST website and acknowledge COST as a funding source. The acknowledgment shall follow the COST guidelines on visual identity.

Visual identity - COST – available here

 

 

 

European Cooperation in Science and Technology (COST) logo
EU flag logo

Funded by the Horizon 2020 Framework Programme
of the European Union